These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6629169)
21. Endothelium: the main actor or choreographer in the remodelling of the retinal microvasculature in diabetes? Tooke JE Diabetologia; 1996 Jun; 39(6):745-6. PubMed ID: 8781773 [No Abstract] [Full Text] [Related]
23. [Role of insulin-like growth factor I in the development of diabetic retinopathy]. Gacka M; Adamiec J Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339 [TBL] [Abstract][Full Text] [Related]
24. The eye, the kidney and microcirculation. Blum M; Saemann A; Wolf G Nephrol Dial Transplant; 2011 Jan; 26(1):4-6. PubMed ID: 20628181 [No Abstract] [Full Text] [Related]
25. Current concepts of pathogenesis of diabetic retinopathy: a dysproteinemia. Little HL; Sacks A; Vassiliadis A; Greer R Trans Am Ophthalmol Soc; 1977; 75():397-426. PubMed ID: 613527 [No Abstract] [Full Text] [Related]
27. Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy. Unoki N; Nishijima K; Sakamoto A; Kita M; Watanabe D; Hangai M; Kimura T; Kawagoe N; Ohta M; Yoshimura N Am J Ophthalmol; 2007 Nov; 144(5):755-760. PubMed ID: 17868632 [TBL] [Abstract][Full Text] [Related]
28. Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes. Porta M Diabetologia; 1996 Jun; 39(6):739-44. PubMed ID: 8781772 [No Abstract] [Full Text] [Related]
30. Novel role of erythropoietin in proliferative diabetic retinopathy. Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772 [TBL] [Abstract][Full Text] [Related]
31. Retinopathy in monkeys with spontaneous type 2 diabetes. Kim SY; Johnson MA; McLeod DS; Alexander T; Otsuji T; Steidl SM; Hansen BC; Lutty GA Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4543-53. PubMed ID: 15557466 [TBL] [Abstract][Full Text] [Related]
35. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy]. Adamiec J; Oficjalska-Młyńczak J Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844 [TBL] [Abstract][Full Text] [Related]
36. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Li W; Yanoff M; Liu X; Ye X Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318 [TBL] [Abstract][Full Text] [Related]
37. Capillary microaneurisms and shunt vessels in diabetic retinopathy. A hypothesis on pathogenesis and prevention. Kornzweig AL Isr J Med Sci; 1972; 8(8):1316-22. PubMed ID: 4647780 [No Abstract] [Full Text] [Related]
38. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats. Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362 [TBL] [Abstract][Full Text] [Related]
39. Progression of diabetic retinopathy following coronary artery bypass graft. Chadha V; Styles C Eye (Lond); 2007 Jun; 21(6):864-5. PubMed ID: 17293787 [No Abstract] [Full Text] [Related]
40. An igf-I gene polymorphism modifies the risk of diabetic retinopathy. Rietveld I; Ikram MK; Vingerling JR; Hofman A; Pols HA; Lamberts SW; de Jong PT; van Duijn CM; Janssen JA Diabetes; 2006 Aug; 55(8):2387-91. PubMed ID: 16873705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]